Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
Friday
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health | FMCG | Executive
         
Latest Jobs
Exclusive vacancies may not be shown here, please contact Michelle on +44 1494 818 024 or michelle@zenopa.com for more information.
Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Michelle Maggs
Account Manager
michelle@zenopa.com
+44 1494 818 024

Testimonials
I have been working through a contract with Zenopa since March 2012. I actually find this approach more beneficial to me as I have someone independent from the company who I can talk to about any issu...
Jennifer, 2012

Novartis Animal Health launches new flukicide for cattle and sheep

15 December 2010 00:00 in Animal Health Supplier News


Novartis Animal Health has launched a versatile new flukicide product that can be used to treat fluke among both cattle and sheep.

The new Fasinex 100 offering is based on the veterinary medicine firm's previous Fasinex 5 Percent and Fasinex 10 Percent products, which treated each species individually, reports Farmers Weekly Interactive.

According to the manufacturer, the ability to treat both livestock types simultaneously will reduce the likelihood of re-infection on dual-species sites.

Moreover, the meat-withhold period in sheep has been cut down to 35 days, a reduction of 21 days when compared to the previous Fasinex 5 Percent treatment.

Simon Harris, Novartis Animal Health's Fasinex UK brand manager, said: "Additionally, the double-strength formulation for sheep compared to Fasinex 5 Percent means only half as much costly packaging needs disposing."

The Fasinex range is also intended for use among goats and is well-tolerated by animals of any age and breed, including pregnant specimens and those suffering poor health.ADNFCR-8000103-ID-800293326-ADNFCR

Other news stories from 15/12/2010

Related news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Adfero News Agency



   
© Copyright 2013 Zenopa Ltd